These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 30695776

  • 1. Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling.
    Ding Z, Shi H, Yang W.
    Pharmacology; 2019; 103(3-4):163-172. PubMed ID: 30695776
    [Abstract] [Full Text] [Related]

  • 2. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
    Hou JM, Xue Y, Lin QM.
    Acta Pharmacol Sin; 2012 Oct; 33(10):1277-84. PubMed ID: 22902986
    [Abstract] [Full Text] [Related]

  • 3. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
    Li G, Bu J, Zhu Y, Xiao X, Liang Z, Zhang R.
    Int J Clin Exp Pathol; 2015 Oct; 8(12):15684-95. PubMed ID: 26884838
    [Abstract] [Full Text] [Related]

  • 4. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F, Tan F, Tong W, Fan Q, Ye S, Lu S, Teng Z, Han M, Zhang M, Chai Y.
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [Abstract] [Full Text] [Related]

  • 5. Thyrotoxicosis Involves β2-Adrenoceptor Signaling to Negatively Affect Microarchitecture and Biomechanical Properties of the Femur.
    Neofiti-Papi B, Albuquerque RP, Miranda-Rodrigues M, Gonçalves NJN, Jorgetti V, Brum PC, Ferreira JCB, Gouveia CHA.
    Thyroid; 2019 Aug; 29(8):1060-1072. PubMed ID: 31264512
    [Abstract] [Full Text] [Related]

  • 6. Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis.
    Liu WJ, Jiang ZM, Chen Y, Xiao PT, Wang ZY, Huang TQ, Liu EH.
    J Ethnopharmacol; 2020 Jul 15; 257():112871. PubMed ID: 32325182
    [Abstract] [Full Text] [Related]

  • 7. In vivo and in vitro action mechanism of treatment of glucocorticoid-induced osteoporosis by regulation of osteoprotegerin/receptor activator of nuclear factor-κB pathways by denshensu.
    Li J.
    Cell Mol Biol (Noisy-le-grand); 2023 Oct 31; 69(10):67-74. PubMed ID: 37953581
    [Abstract] [Full Text] [Related]

  • 8. Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.
    Liu C, Wang L, Zhu R, Liu H, Ma R, Chen B, Li L, Guo Y, Jia Q, Shi S, Zhao D, Mo F, Zhao B, Niu J, Fu M, Orekhov AN, Brömme D, Gao S, Zhang D.
    Osteoporos Int; 2019 Feb 31; 30(2):491-505. PubMed ID: 30151623
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W, Zhang X.
    Mol Med Rep; 2015 May 31; 11(5):3212-8. PubMed ID: 25572286
    [Abstract] [Full Text] [Related]

  • 13. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
    Lu J, Liu F, Liu D, Du H, Hao J, Yang X, Cui W.
    Exp Biol Med (Maywood); 2016 Jun 31; 241(11):1237-49. PubMed ID: 26908571
    [Abstract] [Full Text] [Related]

  • 14. Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.
    Staines KA, Hopkinson M, Dillon S, Stephen LA, Fleming R, Sophocleous A, Buttle DJ, Pitsillides AA, Farquharson C.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31894854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Receptor Activator of Nuclear Factor κ-Β Ligand/Osteoprotegerin Axis in Adults with Hb S/β-Thalassemia and β-Thalassemia Trait.
    Tombak A, Boztepe B, Akbayir S, Dogru G, Sungur MA.
    Hemoglobin; 2020 Sep 31; 44(5):334-337. PubMed ID: 32873083
    [Abstract] [Full Text] [Related]

  • 17. The wakefulness promoting drug Modafinil causes adenosine receptor-mediated upregulation of receptor activator of nuclear factor κB ligand in osteoblasts: Negative impact of the drug on peak bone accrual in rats.
    Pal China S, Pal S, Chattopadhyay S, Porwal K, Mittal M, Sanyal S, Chattopadhyay N.
    Toxicol Appl Pharmacol; 2018 Jun 01; 348():22-31. PubMed ID: 29649498
    [Abstract] [Full Text] [Related]

  • 18. Alginate oligosaccharide alleviates senile osteoporosis via the RANKL-RANK pathway in D-galactose-induced C57BL/6J mice.
    Wang S, Feng W, Liu J, Wang X, Zhong L, Lv C, Feng M, An N, Mao Y.
    Chem Biol Drug Des; 2022 Jan 01; 99(1):46-55. PubMed ID: 34145772
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.
    Zhang Y, Liu MW, He Y, Deng N, Chen Y, Huang J, Xie W.
    Int J Immunopathol Pharmacol; 2020 Jan 01; 34():2058738420941762. PubMed ID: 32674689
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.
    Peng WX, Ye C, Dong WT, Yang LL, Wang CQ, Wei ZA, Wu JH, Li Q, Deng J, Zhang J.
    Exp Biol Med (Maywood); 2017 Jun 01; 242(12):1234-1243. PubMed ID: 28454497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.